Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2009 1
2013 1
2014 2
2015 5
2016 1
2017 4
2018 3
2019 2
2020 3
2021 8
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2.
Han X, Wang Y, Li S, Hu C, Li T, Gu C, Wang K, Shen M, Wang J, Hu J, Wu R, Mu S, Gong F, Chen Q, Gao F, Huang J, Long Y, Luo F, Song S, Long S, Hao Y, Li L, Wu Y, Xu W, Cai X, Gao Q, Zhang G, He C, Deng K, Du L, Nai Y, Wang W, Xie Y, Qu D, Huang A, Tang N, Jin A. Han X, et al. Among authors: mu s. Front Immunol. 2021 Mar 22;12:653189. doi: 10.3389/fimmu.2021.653189. eCollection 2021. Front Immunol. 2021. PMID: 33828563 Free PMC article.
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants.
Li T, Han X, Gu C, Guo H, Zhang H, Wang Y, Hu C, Wang K, Liu F, Luo F, Zhang Y, Hu J, Wang W, Li S, Hao Y, Shen M, Huang J, Long Y, Song S, Wu R, Mu S, Chen Q, Gao F, Wang J, Long S, Li L, Wu Y, Gao Y, Xu W, Cai X, Qu D, Zhang Z, Zhang H, Li N, Gao Q, Zhang G, He C, Wang W, Ji X, Tang N, Yuan Z, Xie Y, Yang H, Zhang B, Huang A, Jin A. Li T, et al. Among authors: mu s. Nat Commun. 2021 Nov 2;12(1):6304. doi: 10.1038/s41467-021-26539-7. Nat Commun. 2021. PMID: 34728625 Free PMC article.
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study.
Wu X, Zhu J, Wang J, Lin Z, Yin R, Sun W, Zhou Q, Zhang S, Wang D, Shi H, Gao Y, Huang Y, Li G, Wang X, Cheng Y, Lou G, Gao Q, Wang L, Du X, Pan M, Mu X, Li L, Li M, Mu S, Kong B. Wu X, et al. Among authors: mu s. Clin Cancer Res. 2022 Feb 15;28(4):653-661. doi: 10.1158/1078-0432.CCR-21-1186. Clin Cancer Res. 2022. PMID: 34844979 Free PMC article. Clinical Trial.
37 results